145 related articles for article (PubMed ID: 19930426)
1. Efficacy of butyrate analogues in HT-29 cancer cells.
Ooi CC; Good NM; Williams DB; Lewanowitsch T; Cosgrove LJ; Lockett TJ; Head RJ
Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):482-9. PubMed ID: 19930426
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship of butyrate analogues on apoptosis, proliferation and histone deacetylase activity in HCT-116 human colorectal cancer cells.
Ooi CC; Good NM; Williams DB; Lewanowitsch T; Cosgrove LJ; Lockett TJ; Head RJ
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):905-11. PubMed ID: 20497425
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential pathways involved in induction of apoptosis by butyrate and 4-benzoylbutyrate in HT29 colorectal cancer cells.
Fung KY; Ooi CC; Lewanowitsch T; Tan S; Tan HT; Lim TK; Lin Q; Williams DB; Lockett TJ; Cosgrove LJ; Chung MC; Head RJ
J Proteome Res; 2012 Dec; 11(12):6019-29. PubMed ID: 23057685
[TBL] [Abstract][Full Text] [Related]
4. tert-Butylcarbamate-containing histone deacetylase inhibitors: apoptosis induction, cytodifferentiation, and antiproliferative activities in cancer cells.
Valente S; Trisciuoglio D; Tardugno M; Benedetti R; Labella D; Secci D; Mercurio C; Boggio R; Tomassi S; Di Maro S; Novellino E; Altucci L; Del Bufalo D; Mai A; Cosconati S
ChemMedChem; 2013 May; 8(5):800-11. PubMed ID: 23526814
[TBL] [Abstract][Full Text] [Related]
5. Modulation of butyrate anticancer activity by solid lipid nanoparticle delivery: an in vitro investigation on human breast cancer and leukemia cell lines.
Foglietta F; Serpe L; Canaparo R; Vivenza N; Riccio G; Imbalzano E; Gasco P; Zara GP
J Pharm Pharm Sci; 2014; 17(2):231-47. PubMed ID: 24934552
[TBL] [Abstract][Full Text] [Related]
6. Discovery of potent HDAC inhibitors based on chlamydocin with inhibitory effects on cell migration.
Wang S; Li X; Wei Y; Xiu Z; Nishino N
ChemMedChem; 2014 Mar; 9(3):627-37. PubMed ID: 24285590
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel 2-aminobenzamides containing dithiocarbamate moiety as histone deacetylase inhibitors and potent antitumor agents.
Xie R; Li Y; Tang P; Yuan Q
Eur J Med Chem; 2018 Jan; 143():320-333. PubMed ID: 29202397
[TBL] [Abstract][Full Text] [Related]
8. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation.
Hinnebusch BF; Meng S; Wu JT; Archer SY; Hodin RA
J Nutr; 2002 May; 132(5):1012-7. PubMed ID: 11983830
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of a new generation of substituted purine hydroxamate analogs as histone deacetylase inhibitors.
Liu R; Wang J; Tang W; Fang H
Bioorg Med Chem; 2016 Apr; 24(7):1446-54. PubMed ID: 26907204
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase (HDAC) inhibitory and antiproliferative activities of phenolic-rich extracts derived from the rhizome of Hydnophytum formicarum Jack.: sinapinic acid acts as HDAC inhibitor.
Senawong T; Misuna S; Khaopha S; Nuchadomrong S; Sawatsitang P; Phaosiri C; Surapaitoon A; Sripa B
BMC Complement Altern Med; 2013 Sep; 13():232. PubMed ID: 24053181
[TBL] [Abstract][Full Text] [Related]
11. Novel inhibitors of human histone deacetylases: design, synthesis and bioactivity of 3-alkenoylcoumarines.
Seidel C; Schnekenburger M; Zwergel C; Gaascht F; Mai A; Dicato M; Kirsch G; Valente S; Diederich M
Bioorg Med Chem Lett; 2014 Aug; 24(16):3797-801. PubMed ID: 25042254
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Biological Evaluation of 1-(2-Aminophenyl)-3-arylurea Derivatives as Potential EphA2 and HDAC Dual Inhibitors.
Zhu Y; Ran T; Chen X; Niu J; Zhao S; Lu T; Tang W
Chem Pharm Bull (Tokyo); 2016; 64(8):1136-41. PubMed ID: 27477652
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of Santacruzamate-A based analogues.
Randino R; Gazzerro P; Mazitschek R; Rodriquez M
Bioorg Med Chem; 2017 Dec; 25(24):6486-6491. PubMed ID: 29100734
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitors.
Guan P; Sun F; Hou X; Wang F; Yi F; Xu W; Fang H
Bioorg Med Chem; 2012 Jun; 20(12):3865-72. PubMed ID: 22579621
[TBL] [Abstract][Full Text] [Related]
15. Pyrimidinedione-mediated selective histone deacetylase 6 inhibitors with antitumor activity in colorectal cancer HCT116 cells.
Liu YM; Lee HY; Lai MJ; Pan SL; Huang HL; Kuo FC; Chen MC; Liou JP
Org Biomol Chem; 2015 Oct; 13(40):10226-35. PubMed ID: 26309122
[TBL] [Abstract][Full Text] [Related]
16. Cellular Metabolism and Dose Reveal Carnitine-Dependent and -Independent Mechanisms of Butyrate Oxidation in Colorectal Cancer Cells.
Han A; Bennett N; MacDonald A; Johnstone M; Whelan J; Donohoe DR
J Cell Physiol; 2016 Aug; 231(8):1804-13. PubMed ID: 26661480
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, Molecular Modeling, and Biological Evaluation of Novel Amine-based Histone Deacetylase Inhibitors.
Abdelkarim H; Neelarapu R; Madriaga A; Vaidya AS; Kastrati I; Karumudi B; Wang YT; Taha TY; Thatcher GRJ; Frasor J; Petukhov PA
ChemMedChem; 2017 Dec; 12(24):2030-2043. PubMed ID: 29080240
[TBL] [Abstract][Full Text] [Related]
18. Identification of HDAC6-Selective Inhibitors of Low Cancer Cell Cytotoxicity.
Gaisina IN; Tueckmantel W; Ugolkov A; Shen S; Hoffen J; Dubrovskyi O; Mazar A; Schoon RA; Billadeau D; Kozikowski AP
ChemMedChem; 2016 Jan; 11(1):81-92. PubMed ID: 26592932
[TBL] [Abstract][Full Text] [Related]
19. Butyrate suppresses murine mast cell proliferation and cytokine production through inhibiting histone deacetylase.
Zhang H; Du M; Yang Q; Zhu MJ
J Nutr Biochem; 2016 Jan; 27():299-306. PubMed ID: 26601598
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of novel HDAC inhibitors as potential antitumor agents.
Cheng J; Qin J; Guo S; Qiu H; Zhong Y
Bioorg Med Chem Lett; 2014 Oct; 24(19):4768-4772. PubMed ID: 25182565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]